Clinical Trial Update: A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression [Phase 3]

View source ↗

Summary

A Phase 3 trial update on Abilify (aripiprazole) as an adjunctive treatment for bipolar depression is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Depression, Bipolar | Phase 3 | Status: RECRUITING